AcelRx Pharmaceuticals

The decision makers in AcelRx Pharmaceuticals are Evangeline Cruz, Jeff Vallone, Kathleen Yozie, etc. Click to Find AcelRx Pharmaceuticals decision makers emails.

AcelRx Pharmaceuticals is a specialty pharmaceutical company that focuses on developing and commercializing innovative therapies specifically designed for use in medically supervised settings. The company is particularly recognized for its lead product candidate, Niyad, which aims to provide effective pain management solutions.

AcelRx develops therapies primarily aimed at pain management. Their product pipeline includes innovative solutions that are designed to be administered in controlled environments, such as hospitals or surgical centers, ensuring that patients receive optimal care under professional supervision.

AcelRx operates primarily within the pharmaceutical industry, focusing on pain management and related therapeutic areas. Their products are designed for use in healthcare settings, including hospitals, surgical centers, and other medically supervised environments where effective pain control is critical.

Niyad is AcelRx's lead product candidate, designed for the management of acute pain. It utilizes a unique formulation that allows for rapid onset of pain relief while maintaining a favorable safety profile. Niyad is intended to be administered by healthcare professionals in controlled settings, ensuring that patients receive the appropriate dosage and monitoring.

AcelRx adheres to strict regulatory guidelines and conducts extensive research and clinical trials to ensure the safety and efficacy of its products. The company collaborates with healthcare professionals and regulatory agencies to gather data and feedback, which informs their product development process and ensures compliance with industry standards.

For more detailed information about AcelRx's product offerings, including Niyad and other therapies in development, you can visit their official website at http://www.acelrx.com. The site provides comprehensive information about their products, research initiatives, and the therapeutic areas they focus on.